Mercado Donar ahora Conviértase en Miembro

Carrito (0)

Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Eventos globales

Renaissance London Heathrow Hotel

09 oct 2018 8:00 a.m. - 10 oct 2018 5:30 p.m.

Bath Road, Hounslow, Middlesex, TW6 2AQ, United Kingdom

Value, Access, and Regulatory Strategy Conference

Paving the Way to the Future by Building Bridges

Volver a Agenda

Session 3: Setting the Scene: Digital Health Solutions and Their Impact on Drug Development and Access

Session Chair(s)

Solange Corriol-Rohou, DrMed, MD

CEO, SCR Consulting, France

Digital Healthcare Solutions whether wearables, mobile apps, smart devices, home virtual assistants, predictive analytics, web health portals or blockchain-based electronic medical record systems are increasingly used to deliver personalised, efficient and informed care. However, with such innovation comes trust and responsibility in order to get the full benefits of digitally enabled healthcare services. The European Commission, which is working to provide its citizens access to safe and top quality digital services in health and care, recently released a Communication on Digital Transformation of Health and Care in the Digital Single Market, identifying actions to attain key priorities and build a healthier society. Such topic is also the focus of regulators since both EMA and FDA have started consultations and strengthening their expertise capabilities. But those technologies would need to be developed in conformity with data protection rules and other cybersecurity requirements.

Speakers representing the different organisations involved will provide their perspective via short presentations prior to joining a panel session where main challenges will be discussed.

Speaker(s)

European Commission Perspective

Katja Neubauer

Team Leader eHealth, Unit B3 - Cross Border Healthcare & eHealth, DG SANTE, European Commission, Belgium

EMA Perspective

Michael Berntgen, PhD

Head of Scientific Evidence Generation, European Medicines Agency, Netherlands

Industry Perspective

Thomas Metcalfe, MBA

Personalised Healthcare Ecosystems, F. Hoffmann-La Roche, Switzerland

Patient Perspective

Ines Hernando

Patient Advocate, EURORDIS, France

Sini Eskola, MPharm, MS, MSc

Head of International Regulatory Policy and Innovation, Takeda, Belgium

Academic Perspective

Cynthia Iglesias

Senior Health Economist/Health Services Researcher, Department of Health Sciences, University of York, United Kingdom

¿Tiene una cuenta?